OVEREXPRESSION OF IL-6 BUT NOT IL-8 INCREASES PACLITAXEL RESISTANCE OF U-2OS HUMAN OSTEOSARCOMA CELLS

This publication has 23 references indexed in Scilit:

• Cytokines IL-1beta, IL-2, IL-6, IL-8, MCP-1, GM-CSF and TNFalpha in patients with epithelial ovarian cancer and their relationship to treatment with paclitaxel
  International Journal of Gynecologic Cancer, 2000
• Taxol-resistant epithelial ovarian tumors are associated with altered expression of specific beta-tubulin isotypes.
  Journal of Clinical Investigation, 1997
• Paclitaxel has moderate activity in squamous cervix cancer. A Gynecologic Oncology Group study.
  Journal of Clinical Oncology, 1996
• Serum levels of cytokines in patients with colorectal cancer: Possible involvement of interleukin-6 and interleukin-8 in hematogenous metastasis
  The Esophagus, 1994
• Growth Inhibition of Ovarian Cancer Cells Induced by Antisense IL-6 Oligonucleotides
  Gynecologic Oncology, 1993
• Interleukin-6 in Biology and Medicine
  Published by Elsevier ,1993
• Quantitation of tumor necrosis factor-α, interleukin-lβ, and interleukin-6 in the effusions of ovarian epithelial neoplasms
  American Journal of Obstetrics and Gynecology, 1992
• AIDS Kaposi sarcoma-derived cells produce and respond to interleukin 6.
  Proceedings of the National Academy of Sciences, 1990
• A possible autocrine role for interleukin-6 in two lymphoma cell lines
  Blood, 1989
• Autocrine generation and requirement of BSF-2/IL-6 for human multiple myelomas
  Nature, 1988